RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 11.487
NA - Nord America 5.000
EU - Europa 2.306
SA - Sud America 602
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 89
OC - Oceania 16
Totale 19.630
Nazione #
SG - Singapore 8.999
US - Stati Uniti d'America 4.760
IT - Italia 1.256
CN - Cina 1.131
HK - Hong Kong 598
BR - Brasile 408
VN - Vietnam 266
GB - Regno Unito 235
FR - Francia 221
DE - Germania 187
BD - Bangladesh 143
CA - Canada 111
NL - Olanda 103
IN - India 97
AR - Argentina 61
EE - Estonia 58
FI - Finlandia 49
ID - Indonesia 48
MX - Messico 43
EC - Ecuador 38
CO - Colombia 35
ZA - Sudafrica 31
TR - Turchia 28
IQ - Iraq 25
UA - Ucraina 22
PH - Filippine 20
SE - Svezia 20
JP - Giappone 19
ES - Italia 18
AT - Austria 17
CL - Cile 16
CR - Costa Rica 16
CZ - Repubblica Ceca 16
RU - Federazione Russa 16
SA - Arabia Saudita 16
VE - Venezuela 15
PL - Polonia 14
AU - Australia 13
GT - Guatemala 13
JM - Giamaica 13
PE - Perù 12
PK - Pakistan 12
MD - Moldavia 11
TN - Tunisia 11
NI - Nicaragua 10
MA - Marocco 9
RO - Romania 9
KZ - Kazakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
LT - Lituania 7
DO - Repubblica Dominicana 6
KE - Kenya 6
MY - Malesia 6
NP - Nepal 6
TH - Thailandia 6
TW - Taiwan 6
UY - Uruguay 6
BE - Belgio 5
BO - Bolivia 5
CH - Svizzera 5
HU - Ungheria 5
IE - Irlanda 5
SV - El Salvador 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
OM - Oman 4
PY - Paraguay 4
CW - ???statistics.table.value.countryCode.CW??? 3
GE - Georgia 3
GP - Guadalupe 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HT - Haiti 2
IR - Iran 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SN - Senegal 2
VI - Stati Uniti Isole Vergini 2
Totale 19.469
Città #
San Jose 1.243
Ashburn 842
Singapore 781
Rome 690
Hong Kong 529
Hefei 394
Council Bluffs 303
Beijing 274
Dallas 234
Columbus 216
Boardman 197
Lauterbourg 191
London 175
Phoenix 147
Shanghai 138
New York 111
Munich 104
Ho Chi Minh City 99
Los Angeles 94
Santa Clara 93
Hanoi 59
Amsterdam 46
Naples 45
Denver 44
San Francisco 38
Milan 34
Chicago 33
São Paulo 31
Seattle 28
Turku 28
Washington 28
Pune 27
Toronto 26
Atlanta 22
Helsinki 21
Brooklyn 20
Montreal 20
Mexico City 19
Charlotte 16
Las Vegas 16
Quito 16
Buffalo 15
Bogotá 14
Chennai 14
Boston 13
Orem 13
Palermo 13
Brno 12
Haiphong 12
Johannesburg 12
Rio de Janeiro 12
Tokyo 12
Florence 11
Frankfurt am Main 11
Guatemala City 11
San José 11
Sona 11
St Louis 11
Bari 10
Bologna 10
Brasília 10
Guayaquil 10
Lima 10
Managua 10
Manchester 10
Nuremberg 10
Stockholm 10
Warsaw 10
West Jordan 10
Curitiba 9
Jakarta 9
Philadelphia 9
Biên Hòa 8
Da Nang 8
Guangzhou 8
Hải Dương 8
Manaus 8
Newark 8
Tashkent 8
Turin 8
Baghdad 7
Buenos Aires 7
Dhaka 7
Miami 7
Piscataway 7
Santiago 7
Ankara 6
Belo Horizonte 6
Guarulhos 6
Hangzhou 6
Hanover 6
Houston 6
Kingston 6
Manila 6
Nairobi 6
New Delhi 6
Pittsburgh 6
Queens 6
Redmond 6
San Salvador 6
Totale 8.007
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 350
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 342
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 282
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 268
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 258
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 253
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 252
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 241
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 238
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 238
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 237
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 233
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 232
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 231
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 229
Exploring Deep Pathomics in Lung Cancer 228
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 227
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 225
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 224
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 224
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 223
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 222
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 221
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 221
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 220
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 216
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 216
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 215
Preventing Cardiotoxicity in Personalized Breast Irradiation 214
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 212
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 209
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 196
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 182
A deep learning approach for overall survival prediction in lung cancer with missing values 174
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 170
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 165
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 158
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 148
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 145
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 143
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 142
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 142
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 141
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 140
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 140
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 138
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 138
MR imaging of rectal cancer before and after chemoradiation therapy 138
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 136
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 134
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 134
Evaluating GANs in Medical Imaging 133
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 132
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 132
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 129
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 128
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 127
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 124
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 123
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 121
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 118
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 118
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 116
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 116
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 115
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 113
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 112
Chemoradiation for stage III non-small cell lung cancer 110
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 109
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 108
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 100
Precision radiotherapy by SPECT lung functional imaging in NSCLC 100
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 99
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort 93
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 90
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 85
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 85
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 73
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 72
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 71
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 67
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study 66
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 66
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis 66
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement 66
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 65
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 64
Protective Role of Natural Compounds under Radiation-Induced Injury 64
V5 and High Sensitivity Cardiac Troponin T for Early Detection of Cardiac Toxicity During Left Breast Cancer Irradiation 62
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 62
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 60
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 60
The COVID-19 Status of Patients Is an Essential Determinant for Decision-Making by Radiation Oncologists: A European Survey 60
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 59
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 59
Radiation therapy of breast cancer. Reasoned approach to a clinical case 59
Protective Effects of Grape Seed Extract on Lipopolysaccharide Exposure and Radiation-Induced Intestinal Mucosal Damage: Insights from an In Vitro Study 58
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 58
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 58
Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART 57
Totale 14.793
Categoria #
all - tutte 102.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022208 0 0 0 5 1 3 6 6 13 7 0 167
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024590 21 62 36 35 60 250 14 35 4 22 11 40
2024/20259.985 95 48 220 64 111 218 153 34 520 723 3.590 4.209
2025/20266.820 612 324 483 740 294 400 1.803 474 560 586 290 254
2026/20271.843 122 690 540 491 0 0 0 0 0 0 0 0
Totale 19.630